人物背景 - Albert Anthony是克罗地亚裔美国商业作家 使用笔名在投资者平台Seeking Alpha发表观点 拥有超过1千名粉丝 同时在Investing com等平台撰稿 并计划于2025年在亚马逊出版著作《金融市场：下一代》[1] - 自称金融市场新一代分析师 拥有非传统金融背景 曾在美国多家财富500强IT企业担任技术支持团队分析师 这段数据驱动且流程导向的经历为其2021年创立股票研究公司Albert Anthony & Company奠定基础 目前100%远程运营该公司[1] - 成长于纽约市克罗地亚移民家庭 曾在美国奥斯汀IT行业工作 并频繁参与克罗地亚商业创新会议、贸易展览和小组讨论 该国是南欧快速增长的经济体[1] - 毕业于德鲁大学 持续接受企业金融协会等机构的培训认证 除金融媒体外 还活跃于欧洲演艺经纪公司 参与过5部影视作品拍摄 并在克罗地亚地区媒体出镜 计划2025年推出YouTube节目《Albert Anthony的金融市场》延续其市场评论工作[1]

BURLINGTON, N.C., June 26, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2025 before the market opens on Thursday, July 24, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.The call wil ...

Carrying a Zacks Rank #3 (Hold) at present, the laboratory service provider is concentrating more on areas that represent major growth opportunities and are expected to grow significantly faster than other therapeutic areas. It maintains a solid pipeline of potential acquisitions that fit its financial strategy and will enhance its organic growth. Additionally, the success of the LaunchPad initiative and a solid financial footing are highly encouraging for the company. Based in Burlington, NC, Labcorp offer ...

Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapiesPITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today the company has successfully developed 3D organoid models exclusively for Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services. As part of an ongoing agreement, Predictive Oncology recentl ...

Key Takeaways Labcorp targets growth through specialty testing in oncology, neurology and women's health. LH expanded with key acquisitions and partnerships to boost its national and clinical presence. Labcorp's solid balance sheet supports dividends and buybacks despite rising competitive pressure.Labcorp Holdings Inc. (LH) , or Labcorp’s strong focus on key areas such as oncology, women’s health, autoimmune disease and neurology is poised to help it grow in the upcoming quarters. The company maintains a ...

Key Takeaways Labcorp expanded its precision oncology portfolio with new solid tumor and hematologic cancer tests. LH added HRD testing and HER2 subtyping, and launched the Rapid AML Panel for advanced cancer profiling. Labcorp launched a global digital pathology platform to boost companion diagnostic development efforts.Labcorp (LH) recently announced the expansion of its precision oncology portfolio, which includes new test offerings for solid tumor and hematologic malignancies and enhanced biopharma so ...

LOS ANGELES, June 02, 2025 (GLOBE NEWSWIRE) -- InStride, a leading provider of strategic education and skilling solutions, has facilitated a unique partnership between Arizona State University’s College of Health Solutions and Labcorp, a global leader of innovative and comprehensive laboratory services, to launch a Master of Science in Cytology. ASU’s online graduate program addresses the severe shortage of cytotechnologists—specialists essential to cancer detection and diagnostics. With only 19 training pr ...

New test offerings target solid tumors and hematologic malignanciesEnhanced biopharma services support accelerated clinical trials and companion diagnostic developmentBURLINGTON, N.C., May 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its precision oncology portfolio. The additions include new test offerings for solid tumor and hematologic malignancies and enhanced biopharma solutions designed to accelerate ...

It has been about a month since the last earnings report for Labcorp (LH) . Shares have added about 2.5% in that time frame, underperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Labcorp due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.How Have Estimates Been Moving Since Then?It turns out ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are t ...